Bio-Techne Corp. buy melinda
Start price
21.11.17
/
50%
€8.26
Target price
30.11.17
€8.44
Performance (%)
2.23%
End price
30.11.17
€8.45
Summary
This prediction ended on 30.11.17 with a price of €8.45. The BUY prediction by melinda finished with a performance of 2.23%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio-Techne Corp. | -6.034% | -6.034% | -23.239% | -26.351% |
| iShares Core DAX® | -1.553% | -0.123% | 12.654% | 57.846% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.546% | 93.736% |
| iShares Nikkei 225® | 1.640% | 5.468% | 17.939% | 51.788% |
| iShares S&P 500 | 0.114% | -0.217% | 1.586% | 61.648% |
Comments by melinda for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne Corp. engagiert in der Entwicklung, Herstellung und Verkauf von Biotechnologie Reagenzien und Instrumente für die Forschung und markets.It klinische Diagnose ist in drei Segmente sind: Biotechnologie, Protein-Plattformen, und Diagnostics.